Step therapy use protocol for insulin drugs prohibition

The bill MN SF2071 aims to prohibit the use of step therapy protocols for insulin medications. Step therapy requires patients to try and fail on cheaper medications before being approved for more expensive ones. This legislation seeks to ensure that patients can access the insulin they need without unnecessary delays or barriers.

Supporters of MN SF2071 would argue that this bill is essential for protecting the health and well-being of individuals with diabetes. By eliminating step therapy for insulin, it ensures that patients can receive the most effective treatment without facing hurdles that could jeopardize their health.

Critics of MN SF2071 might argue that the bill could lead to increased healthcare costs and insurance premiums. They may contend that step therapy protocols are a necessary tool for managing medication costs and ensuring that patients are prescribed the most appropriate treatments based on their medical history.